valneva Pfizer Pays Valneva $130M for a Bite at a Lyme Disease Vaccine By xconomy.com Published On :: Fri, 01 May 2020 22:44:06 +0000 If you’re looking for a Lyme disease vaccine, you can choose from among several—for your dog. A vaccine for humans hasn’t been available for years and few companies have tried to fill that void. Valneva has advanced its Lyme vaccine candidate to mid-stage clinical testing, and the company now has the help of drug giant […] Full Article Europe National blog main New York blog main New York top stories Biotech Centers for Disease Control and Prevention Cholera clinical trials deals Encephalitis FDA GlaxoSmithKline Japanese encephalitis Life Sciences Lyme disease LYMErix Pfizer pneumococcal disease Prevnar SmithKline Beecham Thomas Lingelbach Valneva